Anika Therapeutics
ANIK
ANIK
123 hedge funds and large institutions have $117M invested in Anika Therapeutics in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 53 increasing their positions, 34 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $115M → $117M (+$2.02M)
0.41% less ownership
Funds ownership: 84.83% → 84.43% (-0.41%)
Holders
123
Holding in Top 10
–
Calls
$40K
Puts
$6K
Top Buyers
| 1 | +$3.62M | |
| 2 | +$1.47M | |
| 3 | +$1.17M | |
| 4 |
Goldman Sachs
New York
|
+$957K |
| 5 |
Two Sigma Advisers
New York
|
+$858K |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$1.02M | |
| 3 | -$835K | |
| 4 |
Millennium Management
New York
|
-$582K |
| 5 |
CM
Capital Management
Glen Allen,
Virginia
|
-$486K |
